What's New in Obesity Treatment?
US$ 20.08
glp 1 military MOAA glp 1 dpp 4 pathway
Description
Effectiveness and tolerability of liraglutide as add-on treatment in patients with obesity and high-frequency or chronic migraine: a prospective pilot study
By 20292030, real-world evidence comes to the fore
Secondary endpoints included changes from baseline FPG levels, insulin, C-peptide, and pro-insulin
Davies et al, 2018
Clinical trials did not show increased nodule incidence
